Denka Co Ltd
TSE:4061

Watchlist Manager
Denka Co Ltd Logo
Denka Co Ltd
TSE:4061
Watchlist
Price: 2 104.5 JPY Market Closed
Market Cap: 181.4B JPY
Have any thoughts about
Denka Co Ltd?
Write Note

Net Margin
Denka Co Ltd

2.2%
Current
4%
Average
4.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.2%
=
Net Income
8.8B
/
Revenue
396.9B

Net Margin Across Competitors

Country JP
Market Cap 181.4B JPY
Net Margin
2%
Country SA
Market Cap 228.3B SAR
Net Margin
1%
Country ID
Market Cap 43.8B USD
Net Margin
-4%
Country ID
Market Cap 642.3T IDR
Net Margin
-4%
Country US
Market Cap 27.9B USD
Net Margin
2%
Country UK
Market Cap 23.9B USD
Net Margin
5%
Country CN
Market Cap 107.8B CNY
Net Margin
3%
Country US
Market Cap 14.7B USD
Net Margin
1%
Country KR
Market Cap 20T KRW
Net Margin
1%
Country CN
Market Cap 86.8B CNY
Net Margin
1%
Country IN
Market Cap 876.5B INR
Net Margin
16%
No Stocks Found

Denka Co Ltd
Glance View

Market Cap
181.4B JPY
Industry
Chemicals

Denka Co., Ltd. is a fascinating player weaving its intricate narrative into the fabric of the industrial world, rooted in innovation and diversification. Founded in 1915, Denka has evolved from a pioneer in the realm of carbide chemistry to a dynamic force in advanced materials. Today's Denka is a multi-faceted conglomerate operating in several key industries, including chemicals, electronics, healthcare, and infrastructure. The company’s strategy revolves around leveraging its chemical expertise to create high-performance materials. These range from functional elastomers and resins to specialty fertilizers and cement additives. The essence of Denka’s business model lies in turning scientific breakthroughs into practical solutions that enhance everyday life, making its products indispensable across a broad spectrum of industries. The company's ability to generate revenue is tightly linked to its commitment to research and development. By continually refining their production processes, Denka ensures their products remain at the cutting edge of performance and sustainability. In the healthcare sector, Denka has made strides with its influenza vaccine, leveraging its pharmaceutical know-how to meet growing global health demands. Meanwhile, its conductive materials are critical in the burgeoning electronics and electric vehicle markets, meeting the demand for more efficient, eco-friendly components. Denka’s financial well-being is further strengthened by its extensive global network, which allows it to tap into diverse markets, offsetting the volatility inherent in any single industry. Through strategic partnerships and a robust value chain, Denka continues to position itself at the confluence of tradition and innovation, shaping a sustainable future for itself and its clientele.

Intrinsic Value
2 507.4 JPY
Undervaluation 16%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.2%
=
Net Income
8.8B
/
Revenue
396.9B
What is the Net Margin of Denka Co Ltd?

Based on Denka Co Ltd's most recent financial statements, the company has Net Margin of 2.2%.